ALZ exerts its immunomodulatory action through binding to the CD52 antigen and the subsequent lysis and depletion of mature circulating CD52 + immune cells; thus, a transient but profound immunosuppression status with relatively brief B cell lymphopenia and prolonged T-cell lymphopenia, overlaps and is followed by an immune reconstitution phase. Here, CD52 is linked to Decreased total B cell count.